Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Capital/Financing Update 2021

Oct 21, 2021

62616_rns_2021-10-21_c04b4300-677f-434f-8c9e-35915aa22a07.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [144 x 47] intentionally omitted <==

October 21, 2021

BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E) Mumbai - 400 051 Scrip code: 532531 Scrip code: STAR

Dear Sirs,

Sub: Strides announces completion of transaction to acquire manufacturing facility in the US along with basket of ANDAs from Endo International plc

This has reference to our earlier Press Release of August 6, 2021 titled “ Strides inks definitive agreement with Endo to acquire its manufacturing facility in the US along with basket of ANDAs ”.

With reference to above, we wish to inform you that the transaction has now achieved closure.

This is for your information and records.

Thanks & Regards,

For Strides Pharma Science Limited,

==> picture [120 x 49] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [89 x 88] intentionally omitted <==

==> picture [507 x 51] intentionally omitted <==